In summary, our research offers unprecedented insights into the role of TRIM29-mediated PERK signaling in the pathogenesis of viral myocarditis, underscoring the therapeutic efficacy of PERK inhibitors for its treatment. The gene discussed is TRIM29; the disease is viral myocarditis.